VIRI logo

Virios Therapeutics (VIRI) Selling, General & Administrative Expenses

Annual SG&A

$3.72 M
-$526.90 K-12.41%

31 December 2023

VIRI Selling, General & Administrative Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly SG&A

$1.77 M
+$1.03 M+140.70%

30 September 2024

VIRI Quarterly SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM SG&A

-$254.13 M
-$5.73 M-2.30%

30 September 2024

VIRI TTM SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

VIRI Selling, General & Administrative Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-+110.3%-6933.5%
3 y3 years-23.3%+39.1%-5344.8%
5 y5 years+169.9%+476.8%-10000.0%

VIRI Selling, General & Administrative Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall time-62.1%-72.4%-2335.1%

Virios Therapeutics Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sept 2024
-
$1.77 M(+140.7%)
$4.31 M(+25.1%)
June 2024
-
$733.70 K(-24.4%)
$3.44 M(-5.1%)
Mar 2024
-
$970.40 K(+15.6%)
$3.63 M(-2.4%)
Dec 2023
$3.72 M(-12.4%)
$839.80 K(-6.7%)
$3.72 M(+0.6%)
Sept 2023
-
$900.10 K(-2.1%)
$3.70 M(-1.9%)
June 2023
-
$919.40 K(-13.2%)
$3.77 M(-8.4%)
Mar 2023
-
$1.06 M(+29.5%)
$4.11 M(-3.1%)
Dec 2022
$4.25 M(-12.4%)
$818.00 K(-15.7%)
$4.25 M(-9.6%)
Sept 2022
-
$969.90 K(-23.4%)
$4.70 M(-3.7%)
June 2022
-
$1.27 M(+6.2%)
$4.88 M(+4.1%)
Mar 2022
-
$1.19 M(-6.1%)
$4.69 M(-3.3%)
DateAnnualQuarterlyTTM
Dec 2021
$4.85 M(-50.6%)
$1.27 M(+10.3%)
$4.85 M(-51.4%)
Sept 2021
-
$1.15 M(+7.0%)
$9.97 M(-12.4%)
June 2021
-
$1.08 M(-20.4%)
$11.37 M(+5.2%)
Mar 2021
-
$1.35 M(-78.9%)
$10.81 M(+10.2%)
Dec 2020
$9.81 M(+612.1%)
$6.39 M(+150.1%)
$9.81 M(+163.2%)
Sept 2020
-
$2.55 M(+396.0%)
$3.73 M(+145.8%)
June 2020
-
$515.10 K(+46.3%)
$1.52 M(+9.2%)
Mar 2020
-
$352.00 K(+15.0%)
$1.39 M(+33.9%)
Dec 2019
$1.38 M(+24.4%)
$306.20 K(-10.9%)
$1.04 M(+41.9%)
Sept 2019
-
$343.50 K(-11.4%)
$731.00 K(+88.6%)
June 2019
-
$387.50 K
$387.50 K
Dec 2018
$1.11 M
-
-

FAQ

  • What is Virios Therapeutics annual selling, general & administrative expenses?
  • What is the all time high annual SG&A for Virios Therapeutics?
  • What is Virios Therapeutics quarterly selling, general & administrative expenses?
  • What is the all time high quarterly SG&A for Virios Therapeutics?
  • What is Virios Therapeutics quarterly SG&A year-on-year change?
  • What is Virios Therapeutics TTM selling, general & administrative expenses?
  • What is the all time high TTM SG&A for Virios Therapeutics?
  • What is Virios Therapeutics TTM SG&A year-on-year change?

What is Virios Therapeutics annual selling, general & administrative expenses?

The current annual SG&A of VIRI is $3.72 M

What is the all time high annual SG&A for Virios Therapeutics?

Virios Therapeutics all-time high annual selling, general & administrative expenses is $9.81 M

What is Virios Therapeutics quarterly selling, general & administrative expenses?

The current quarterly SG&A of VIRI is $1.77 M

What is the all time high quarterly SG&A for Virios Therapeutics?

Virios Therapeutics all-time high quarterly selling, general & administrative expenses is $6.39 M

What is Virios Therapeutics quarterly SG&A year-on-year change?

Over the past year, VIRI quarterly selling, general & administrative expenses has changed by +$926.21 K (+110.29%)

What is Virios Therapeutics TTM selling, general & administrative expenses?

The current TTM SG&A of VIRI is -$254.13 M

What is the all time high TTM SG&A for Virios Therapeutics?

Virios Therapeutics all-time high TTM selling, general & administrative expenses is $11.37 M

What is Virios Therapeutics TTM SG&A year-on-year change?

Over the past year, VIRI TTM selling, general & administrative expenses has changed by -$257.85 M (-6933.51%)